Skip to main content
Clinical Trials/NCT03061292
NCT03061292
Unknown
N/A

A Randomized, Controlled Trial on Patients Undergoing Cardiac Implantable Electronic Device Implantation With Local Anaesthesia and Sedation With and Without Pectoral Nerve Block

Changi General Hospital1 site in 1 country120 target enrollmentJuly 25, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiac IED Implantation
Sponsor
Changi General Hospital
Enrollment
120
Locations
1
Primary Endpoint
Perioperative pain scores
Last Updated
5 years ago

Overview

Brief Summary

Implantation of cardiac implantable electronic devices are generally carried out using intermittent intravenous conscious sedation combined with local anaesthesia. The main advantage of this technique is in avoiding the potential risks of general anaesthesia. However, the use of this Sedation - Local Anaesthesia technique is not without complications. Peri -procedural hypoxaemia and hypotension are well recognised complications of this technique.

The pectoral nerves (Pecs) blocks are novel techniques to block the pectoral, intercostobrachial, third to sixth intercostals, and the long thoracic nerves. PECS block targets the lateral and median pectoral nerves at an interfascial plane between the pectoralis major and minor muscles.

A case report by Fujiwara et al has described the use of this technique to provide good analgesia during and after these implantation procedures surgery. Pectoral nerves block along with minimal sedation has been used as a safe technique in our local set up as well.

Hence, we propose a randomized, single center, controlled trial on patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation with and without Pectoral Nerve Block.

Detailed Description

Intervention group: Pectoral nerve block will be performed by anaesthetist (not blinded) in cardiac catheterization laboratory using ultrasound guidance and strict aseptic technique. Control group: A sham "block" will be performed by anaesthetist in cardiac catheterization laboratory using strict aseptic technique. Patients of both groups will be monitored by the Cardiologist ( performing the procedure) and the Nurse from the monitoring room. A minimum period of 15 minutes will be allowed following the block, prior to device implantation procedure by cardiologist. Numeric rating scale (NRS) will be used for assessment of pain. The assessment will be carried out at every 15 minutes from the start of the procedure till the end of the procedure (0, 15, 30, 45, 60 minutes etc) and also at specific time points. Numerical rating scale will also be assessed when the patient experiences pain at any point and in the recovery room (0, 15, 30 and if needed, 45, 60 minutes). Further post-operative pain scores will be collected at 4 hours and 8 hours post-procedure.

Registry
clinicaltrials.gov
Start Date
July 25, 2016
End Date
November 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Fulfilled the indication for CIED implantation as defined in 2008 guidelines for device-based therapy of cardiac rhythm abnormalities

Exclusion Criteria

  • Those who receives subcutaneous implantable cardioverter defibrillator
  • Vulnerable subjects (children, prisoners, cognitive impaired persons)
  • Known history of allergy to local anaesthetic medications

Outcomes

Primary Outcomes

Perioperative pain scores

Time Frame: 2 years

Incidence of hypoxia, hypotension and hypopnea in the perioperative period

Time Frame: 2 years

Total dose of sedation used

Time Frame: 2 years

Post-anaesthetic discharge score

Time Frame: 2 years

Perioperative sedation scores

Time Frame: 2 years

Secondary Outcomes

  • Patient satisfaction scores(2 years)
  • Procedurist satisfaction scores(2 years)

Study Sites (1)

Loading locations...

Similar Trials